Cargando…
Modified ticagrelor loading doses according to the vasodilator-stimulated phosphoprotein phosphorylation index improve the clinical outcome in ST-elevation myocardial infarction patients with high on-treatment platelet reactivity
BACKGROUND: Current guidelines recommend a standard ticagrelor loading dose (LD) in ST-segment elevation myocardial infarction (STEMI) patients. However, antiplatelet therapy in STEMI patients at high risk of thrombotic events is suboptimal. The study was conducted to validate whether vasodilator-st...
Autores principales: | Liu, Yaling, Kang, Sheng, Li, Xiaolin, Liu, Zhongwen, Gao, Yang, Wang, Xiaodong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Via Medica
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10635729/ https://www.ncbi.nlm.nih.gov/pubmed/34581430 http://dx.doi.org/10.5603/CJ.a2021.0105 |
Ejemplares similares
-
Comparative effects of fentanyl versus morphine on platelet inhibition induced by ticagrelor in patients with ST-segment elevation myocardial infarction: Full results of the PERSEUS randomized trial
por: Iglesias, Juan F., et al.
Publicado: (2022) -
Gut microbiota induces high platelet response in patients with ST segment elevation myocardial infarction after ticagrelor treatment
por: Zhang, Xi, et al.
Publicado: (2022) -
Platelet-to-Hemoglobin Ratio Is an Important Predictor of In-Hospital Mortality in Patients With ST-Segment Elevation Myocardial Infarction
por: Işık, Ferhat, et al.
Publicado: (2022) -
Examining the Timeliness of ST-elevation Myocardial Infarction Transfers
por: Ward, Michael J., et al.
Publicado: (2021) -
Naltrexone-Associated Non-ST-Elevated Myocardial Infarction
por: Gubitosa, James C, et al.
Publicado: (2020)